Perspective Therapeutics Inc (AMEX: CATX) on Friday, plunged -7.44% from the previous trading day, before settling in for the closing price of $3.9. Within the past 52 weeks, CATX’s price has moved between $1.60 and $16.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -9.86% over the last five years. The company achieved an average annual earnings per share of 5.56%. With a float of $57.62 million, this company’s outstanding shares have now reached $74.26 million.
The firm has a total of 140 workers. Let’s measure their productivity. In terms of profitability, gross margin is -114.04%, operating margin of -24388.89%, and the pretax margin is -28377.19%.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 22.41%, while institutional ownership is 66.80%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.21 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.2) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.73% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 15.09 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 216.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Analysing the last 5-days average volume posted by the [Perspective Therapeutics Inc, CATX], we can find that recorded value of 0.83 million was lower than the volume posted last year of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 50.10%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 66.12%, which indicates a significant increase from 20.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.75, while its 200-day Moving Average is $3.77. Now, the first resistance to watch is $3.86. This is followed by the second major resistance level at $4.11. The third major resistance level sits at $4.28. If the price goes on to break the first support level at $3.43, it is likely to go to the next support level at $3.26. Now, if the price goes above the second support level, the third support stands at $3.01.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 268.09 million based on 74,263K outstanding shares. Right now, sales total 1,450 K and income totals -79,280 K. The company made 340 K in profit during its latest quarter, and -18,180 K in sales during its previous quarter.
